Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Oral administration of GSK269962A produced a profound dose-dependent reduction of systemic blood pressure in spontaneously hypertensive rats
6-²H₄)benzenesulfonyl](²H₄)aniline
2016 Jun 19
InChiKey: GIAVHGFPMPSIFI-UHFFFAOYSA-N
twice-a-day for 7 days) demonstrates >2 log10 reductions in viable bacterial counts in the kidney of the ascending urinary tract infection model against a CTX-M-15-producing strain of E
Nabumetone-d3 Catalog No.:M26482-C Oral administration of GSK269962A producedProduct information CAS Number: 1216770 08 9 Molecular Weight: 231. 30 Formula: C15H16O2 Chemical Name: 4 [6 (H)methoxynaphthalen 2 yl]butan 2 one Smiles: [2H]C([2H])([2H])OC1=CC2=CC=C(CCC(C)=O)C=C2C=C1 InChiKey: BLXXJMDCKKHMKV BMSJAHLVSA N InChi: InChI=1S C15H16O2 c1 11(16)3 4 12 5 6 14 10 15(17 2)8 7 13(14)9 12 h5 10H,3 4H2,1 2H3 i2D3 Technical Data Appearance: Solid Power Purity: 98% (or refer to the Certificate of Analysis) Shipping Condition:
US$ 5107.60
US$ 500.10